These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28682435)

  • 21. Long Non-Coding RNA (lncRNA) X-Inactive Specific Transcript (XIST) Plays a Critical Role in Predicting Clinical Prognosis and Progression of Colorectal Cancer.
    Zhang XT; Pan SX; Wang AH; Kong QY; Jiang KT; Yu ZB
    Med Sci Monit; 2019 Aug; 25():6429-6435. PubMed ID: 31452526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
    Dong Z; Wang Y
    Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of taurine upregulated gene 1 as a predictor of poor outcome in osteosarcoma.
    Wang Q; Chen Q
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S405-S409. PubMed ID: 29970697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic value and mechanism of long non-coding RNA DLEU1 in osteosarcoma].
    Zhang JJ; Yang P; Shang XQ
    Zhongguo Gu Shang; 2023 Jun; 36(6):559-64. PubMed ID: 37366099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of long non-coding RNA PCAT-1 correlates with tumor progression and poor prognosis in gastric cancer.
    Cui WC; Wu YF; Qu HM
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3021-3027. PubMed ID: 28742205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
    Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
    Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential value of lncRNA-BC050642 in osteosarcoma origination and outcomes.
    Yang Y; Fei M; Zhou X; Li Y; Jin D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1859-1866. PubMed ID: 31397185
    [No Abstract]   [Full Text] [Related]  

  • 29. Long noncoding RNA SNHG6 promotes osteosarcoma cell proliferation through regulating p21 and KLF2.
    Ruan J; Zheng L; Hu N; Guan G; Chen J; Zhou X; Li M
    Arch Biochem Biophys; 2018 May; 646():128-136. PubMed ID: 29608878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA Sox4 promotes proliferation and migration by activating Wnt/β-catenin signaling pathway in osteosarcoma.
    Tian Z; Yang G; Jiang P; Zhang L; Wang J; Sun S
    Pharmazie; 2017 Sep; 72(9):537-542. PubMed ID: 29441981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long intergenic non-coding RNA 511 correlates with improved prognosis, and hinders osteosarcoma progression both in vitro and in vivo.
    Qiao S; Qi K; Liu C; Xu C; Ma J; Xu X; Li C; Wang Z
    J Clin Lab Anal; 2020 May; 34(5):e23164. PubMed ID: 31893577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.
    Qu G; Ma Z; Tong W; Yang J
    Mol Med Rep; 2018 Jul; 18(1):779-788. PubMed ID: 29845204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCEPR is a novel clinical biomarker for prognosis and regulates cell proliferation through PCNA in osteosarcoma.
    Teng J; Guo X; Wang H
    J Cell Biochem; 2019 Aug; 120(8):12796-12802. PubMed ID: 30861164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
    Zhang SZ; Cai L; Li B
    Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysis.
    Yang Y; Wang S; Li T
    Oncotarget; 2017 May; 8(21):35234-35243. PubMed ID: 28415638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
    Zhang Y; Meng W; Cui H
    Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
    Li Z; Tang Y; Xing W; Dong W; Wang Z
    Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2.
    Su X; Teng J; Jin G; Li J; Zhao Z; Cao X; Guo Y; Guo M; Li X; Wu J; Wang C; Guo Z; Guo Q
    Biomed Pharmacother; 2019 Jan; 109():788-797. PubMed ID: 30551532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
    Cong M; Li J; Jing R; Li Z
    Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients.
    Uzan VR; Lengert Av; Boldrini É; Penna V; Scapulatempo-Neto C; Scrideli CA; Filho AP; Cavalcante CE; de Oliveira CZ; Lopes LF; Vidal DO
    PLoS One; 2016; 11(6):e0156774. PubMed ID: 27253450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.